Navigation

PCC versus Andexanet Alfa for Factor Xa Reversal

By Donna Wesslen, PharmD, and Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP | on October 9, 2025 | 0 Comment

ED Critical Care

Pages: 1 2 | Single Page

Topics: andexanet alfa Anticoagulants Antithrombotic Reversal Apixaban factor Xa inhibitors Hemorrhage Intracerebral Hemorrhage prothrombin complex concentrate Rivaroxaban

No Responses to “PCC versus Andexanet Alfa for Factor Xa Reversal”

Leave a Reply Cancel Reply

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603